234 related articles for article (PubMed ID: 571358)
41. The source(s) of estrogen production in hirsute women with polycystic ovarian disease as determined by simultaneous adrenal and ovarian venous catheterization.
Wajchenberg BL; Achando SS; Mathor MM; Czeresnia CE; Giannella Neto D; Kirschner MA
Fertil Steril; 1988 Jan; 49(1):56-61. PubMed ID: 3121397
[TBL] [Abstract][Full Text] [Related]
42. Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome.
Aono T; Miyake A; Shioji T; Kinugasa T; Onishi T
J Clin Endocrinol Metab; 1976 Apr; 42(4):696-702. PubMed ID: 177447
[TBL] [Abstract][Full Text] [Related]
43. Decreased follicular phase gonadotropin secretion is associated with impaired estradiol and progesterone secretion during the follicular and luteal phases in normally menstruating women.
Schweiger U; Laessle RG; Tuschl RJ; Broocks A; Krusche T; Pirke KM
J Clin Endocrinol Metab; 1989 May; 68(5):888-92. PubMed ID: 2497129
[TBL] [Abstract][Full Text] [Related]
44. Hyperprolactinaemia in polycystic ovary syndrome.
Lunde O
Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
[TBL] [Abstract][Full Text] [Related]
45. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
46. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease.
DeVane GW; Czekala NM; Judd HL; Yen SS
Am J Obstet Gynecol; 1975 Feb; 121(4):496-500. PubMed ID: 125040
[TBL] [Abstract][Full Text] [Related]
47. Ovarian and adrenal contribuion to peripheral steroids during the menstrual cycle in two hirsute women.
Abraham GE
Obstet Gynecol; 1975 Jul; 46(1):29-36. PubMed ID: 1153134
[No Abstract] [Full Text] [Related]
48. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
van der Westhuizen S; van der Spuy ZM
Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
[TBL] [Abstract][Full Text] [Related]
49. Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS.
Sikka P; Gainder S; Dhaliwal LK; Bagga R; Sialy R; Sahdev S
Int J Fertil Womens Med; 2007; 52(1):41-7. PubMed ID: 17987887
[TBL] [Abstract][Full Text] [Related]
50. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
[TBL] [Abstract][Full Text] [Related]
51. Altered androstenedione and estrone dynamics associated with abnormal hormonal profiles in amenorrheic subjects with weight loss or obesity.
Loughlin T; Cunningham SK; Culliton M; Smyth PP; Meagher DJ; McKenna TJ
Fertil Steril; 1985 May; 43(5):720-5. PubMed ID: 3888679
[TBL] [Abstract][Full Text] [Related]
52. Serum FSH and LH levels in the normal menstrual cycle, amenorrhea and oligomenorrhea.
Talas M; Gazárek F; Stehlíková J; Fingerová H
Endocrinol Exp; 1973; 7(1):80-4. PubMed ID: 4541068
[No Abstract] [Full Text] [Related]
53. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.
J Clin Endocrinol Metab; 1998 May; 83(5):1507-14. PubMed ID: 9589647
[TBL] [Abstract][Full Text] [Related]
54. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
55. [Hyperandrogenemic ovarian insufficiency].
Schwartz U; Moltz L; Hammerstein J
Gynakologe; 1981 Jun; 14(2):119-30. PubMed ID: 6790355
[No Abstract] [Full Text] [Related]
56. Sex hormone binding globulin capacity and serum estradiol levels in girls with hirsutism and menstrual disturbances.
Szamatowicz M; Kulikowski M
Endokrynol Pol; 1982; 33(1-3):59-63. PubMed ID: 6892151
[No Abstract] [Full Text] [Related]
57. Adolescent menstrual irregularity.
Mansfield MJ; Emans SJ
J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
[TBL] [Abstract][Full Text] [Related]
58. Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease.
Chang RJ; Mandel FP; Lu JK; Judd HL
J Clin Endocrinol Metab; 1982 Mar; 54(3):490-4. PubMed ID: 6799536
[TBL] [Abstract][Full Text] [Related]
59. [Clinical and endocrinologic aspects of treatment with pure FSH. A report of experiences].
Graf M; Freundl G
Zentralbl Gynakol; 1990; 112(2):81-90. PubMed ID: 2107649
[TBL] [Abstract][Full Text] [Related]
60. Irregular cycles and steroid hormones in polycystic ovary syndrome.
Doi SA; Al-Zaid M; Towers PA; Scott CJ; Al-Shoumer KA
Hum Reprod; 2005 Sep; 20(9):2402-8. PubMed ID: 15932911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
